title: Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mu1 gene in primary breast cancers: an update with an additional 114 cases.
abstract: We studied the polymorphisms m1 (Msp1 restriction site) and m2 (codon Val substitution) of CYP1A1 gene and the copy number of glutathione S-transferase mu1 (GSTM1) gene on 487 DNA of breast cancer primary tumours from Caucasian group. Tumours of patients aged 55 years and under at diagnosis presented a great proportion of wild m1 (-/-) genotype; 83.6% vs. 69.5% (p < 0.0006), and a higher percentage of copy number of GSTM1 equal or under one copy; 65.2% vs. 53.4% (p < 0.011) for older patients m1 and m2 variants are closely linked (p < 0.0000). Tumour with a low copy number of GSTM1 is correlated with high histological grading (p < 0.01) and high Cathepsin D concentrations (p < 0.02). The combinations of different genotypes showed that association wild m1 (-/-) genotype and copy number of GSTM1 inferior or equal to one copy is correlated with an early onset of breast cancer primary tumour 44% vs. 6.4% for m1 (-/+) or (+/+) genotype and copy number of GSTM1 superior to one (p < 0.0000). The CYP1A1 gene wild form seems to be associated with early cancer development in Caucasian patients.
authors.affiliation: Department of Nuclear Medicine, Centre A, Lacassagne, Nice, France. radioanafx@aol.com
authors.forename: X
authors.initials: X
authors.lastname: Fontana
authors.forename: I
authors.initials: I
authors.lastname: Peyrottes
authors.forename: C
authors.initials: C
authors.lastname: Rossi
authors.forename: P
authors.initials: P
authors.lastname: Leblanc-Talent
authors.forename: F
authors.initials: F
authors.lastname: Ettore
authors.forename: M
authors.initials: M
authors.lastname: Namer
authors.forename: F
authors.initials: F
authors.lastname: Bussière
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000201:enzymology* / Q000235:genetics* / Q000378:metabolism; D002402:Cathepsin D / Q000378:metabolism; D019363:Cytochrome P-450 CYP1A1 / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics; D019003:Deoxyribonuclease HpaII; D005260:Female; D005784:Gene Amplification; D005838:Genotype; D005982:Glutathione Transferase / Q000235:genetics*; D006801:Humans; D008875:Middle Aged; D017354:Point Mutation; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length; D011379:Prognosis; D011506:Proteins / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D000071163:Trefoil Factor-1; D025521:Tumor Suppressor Proteins
chemical_list: D004273:DNA, Neoplasm; D011506:Proteins; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C051838:TFF1 protein, human; D000071163:Trefoil Factor-1; D025521:Tumor Suppressor Proteins; D019363:Cytochrome P-450 CYP1A1; D005982:Glutathione Transferase; D019003:Deoxyribonuclease HpaII; D002402:Cathepsin D